Skin AgingSHFA-30-60NCT07564869
Skin Hydration and Facial Aging in Women Aged 30-60: An Observational Correlational Study Using Bioimpedance Analysis
An observational study of Skin Aging and Skin Hydration, run by IAS Skin Care at 1 site in United States.
Trial summary
This study investigates whether skin hydration levels are related to how old the skin looks. Thirty women aged 30 to 60 years will attend a single visit at a licensed esthetic practice in Florida. Skin moisture will be measured at seven points on the face using the BT-Analyze device. Read more about this study
- Who is it for?
- Ages 30 to 60 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Skin Aging, Skin Hydration, Facial Aging
- What is being tested?
- BT-Analyze Bioimpedance Measurement
- How many people
- 30 participants
- Where
- 1 siteUnited States
- Study dates
- 1 May 2026to 24 May 2026
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 30 to 60 years
- Women only
- Healthy volunteers accepted
- Adult
Study population: Women aged 30 to 60 years recruited from a licensed esthetic practice in Florida, United States. Participants are divided into three age groups of 10 women each: 30-40, 40-50, and 50-60 years.
Who may be able to join
- Female, aged 30 to 60 years Willing to attend one study visit without makeup No cosmetics applied for at least 4 hours prior to the visit Able to acclimate in controlled indoor environment for 20 minutes Signed written informed consent
Who cannot join
- Active dermatological conditions (eczema, psoriasis, rosacea in flare) Injectable cosmetic procedures within the past 6 months Systemic medications affecting skin condition (oral retinoids, systemic corticosteroids) Pregnancy or lactation Uncontrolled systemic conditions known to significantly affect skin (e.g., uncontrolled diabetes mellitus)
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Skin Hydration and Facial Aging: A Cross-Sectional Correlational Observational Study Using BT-Analyze Bioimpedance Assessment Across Seven Facial Zones in Women Aged 30-60 Years
This study investigates whether skin hydration levels are related to how old the skin looks. Thirty women aged 30 to 60 years will attend a single visit at a licensed esthetic practice in Florida. Skin moisture will be measured at seven points on the face using the BT-Analyze device. Photographs will be taken and evaluated by a blinded expert cosmetologist using a standard aging scoring system. The study will determine whether women with lower skin hydration tend to show more visible signs of aging.
Read the detailed description
Skin hydration is maintained through hyaluronic acid, natural moisturizing factor (NMF), and the lipid barrier of the stratum corneum. Dehydration activates matrix metalloproteinases (MMPs) which degrade collagen and elastin, accelerating visible aging. This cross-sectional observational study will enroll 30 women in three age groups (30-40, 40-50, and 50-60 years). Hydration will be assessed using BT-Analyze across seven facial zones. The primary outcome is the Spearman rank correlation between mean hydration score and modified Glogau visual aging score (0-18 points). Covariates include age, Fitzpatrick skin type, daily water intake, menopausal status, and skincare habits.
- Conditions
- Skin Aging, Skin Hydration, Facial Aging, Transepidermal Water Loss
- Being tested
- BT-Analyze Bioimpedance Measurement
- Keywords
- bioimpedance, BT-Analyze, Glogau scale, cosmetology, anti-aging, skin moisture
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
BT-Analyze Bioimpedance MeasurementOther
Non-invasive skin hydration measurement using BT-Analyze bioimpedance device at seven standardized facial zones. No therapeutic intervention is administered.
| Study group | Role | What they receive |
|---|---|---|
| Group 1 - Ages 30-40 | Women aged 30 to 40 years (n=10) Receives: Other: BT-Analyze Bioimpedance Measurement | |
| Group 2 - Ages 40-50 | Women aged 40 to 50 years (n=10) Receives: Other: BT-Analyze Bioimpedance Measurement | |
| Group 3 - Ages 50-60 | Women aged 50 to 60 years (n=10) Receives: Other: BT-Analyze Bioimpedance Measurement |
What is being measured
The primary outcome is the main question the study is designed to answer.
Spearman Correlation Between BT-Analyze Mean Score and Modified Glogau Visual Aging Score
Spearman rank correlation coefficient (rs) between mean BT-Analyze hydration score (mean of seven facial zones, 0-65 units) and total modified Glogau visual aging score (0-18 points) assessed by a blinded expert cosmetologist.
Measured: At single study visit (Day 1)
Secondary outcomes (1)
BT-Analyze Score Comparison Across Age Groups
Kruskal-Wallis comparison of mean BT-Analyze hydration scores between three age groups (30-40, 40-50, 50-60 years).
Measured: At single study visit (Day 1)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 May 2026
- Study start1 May 2026
- Primary completion13 May 2026
- Study completion24 May 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Skin AgingStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 30 participants (actual)
Sponsor and investigators
- Lead sponsor
- IAS Skin Care
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Principal investigator, Olga Ias, IAS Skin Care
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07564869
- Sponsor's protocol ID
- IAS-SKIN-2026-001
- Acronym
- SHFA-30-60
- Status last verified
- May 2026
- First submitted
- 27 Apr 2026
- Last updated
- 1 Jun 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 1 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Skin Hydration and Facial Aging: A Cross-Sectional Correlational Observational Study Using BT-Analyze Bioimpedance Assessment Across Seven Facial Zones in Women Aged 30-60 Years
- ClinicalTrials.gov ID
- NCT07564869
- Acronym / sponsor ID
- SHFA-30-60 / IAS-SKIN-2026-001
- Conditions
- Skin Aging, Skin Hydration, Facial Aging, Transepidermal Water Loss
- Keywords
- bioimpedance, BT-Analyze, Glogau scale, cosmetology, anti-aging, skin moisture
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 30 participants (actual)
- Lead sponsor
- IAS Skin CareIndustry (pharma, biotech, devices)
- Study start
- 1 May 2026 (actual)
- Primary completion
- 13 May 2026 (actual)
- Study completion
- 24 May 2026 (actual)
- First posted
- 4 May 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study investigates whether skin hydration levels are related to how old the skin looks. Thirty women aged 30 to 60 years will attend a single visit at a licensed esthetic practice in Florida. Skin moisture will be measured at seven points on the face using the BT-Analyze device. Photographs will be taken and evaluated by a blinded expert cosmetologist using a standard aging scoring system. The study will determine whether women with lower skin hydration tend to show more visible signs of aging.
Detailed description
Skin hydration is maintained through hyaluronic acid, natural moisturizing factor (NMF), and the lipid barrier of the stratum corneum. Dehydration activates matrix metalloproteinases (MMPs) which degrade collagen and elastin, accelerating visible aging. This cross-sectional observational study will enroll 30 women in three age groups (30-40, 40-50, and 50-60 years). Hydration will be assessed using BT-Analyze across seven facial zones. The primary outcome is the Spearman rank correlation between mean hydration score and modified Glogau visual aging score (0-18 points). Covariates include age, Fitzpatrick skin type, daily water intake, menopausal status, and skincare habits.
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Group 1 - Ages 30-40 | – | Other: BT-Analyze Bioimpedance MeasurementWomen aged 30 to 40 years (n=10) |
| Group 2 - Ages 40-50 | – | Other: BT-Analyze Bioimpedance MeasurementWomen aged 40 to 50 years (n=10) |
| Group 3 - Ages 50-60 | – | Other: BT-Analyze Bioimpedance MeasurementWomen aged 50 to 60 years (n=10) |
Who may qualify
- Ages
- 30 to 60 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult
- Study population
- Women aged 30 to 60 years recruited from a licensed esthetic practice in Florida, United States. Participants are divided into three age groups of 10 women each: 30-40, 40-50, and 50-60 years.
Key inclusion criteria (1 listed)
- Female, aged 30 to 60 years Willing to attend one study visit without makeup No cosmetics applied for at least 4 hours prior to the visit Able to acclimate in controlled indoor environment for 20 minutes Signed written informed consent
Key exclusion criteria (1 listed)
- Active dermatological conditions (eczema, psoriasis, rosacea in flare) Injectable cosmetic procedures within the past 6 months Systemic medications affecting skin condition (oral retinoids, systemic corticosteroids) Pregnancy or lactation Uncontrolled systemic conditions known to significantly affect skin (e.g., uncontrolled diabetes mellitus)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| BT-Analyze Bioimpedance MeasurementNon-invasive skin hydration measurement using BT-Analyze bioimpedance device at seven standardized facial zones. No therapeutic intervention is administered. | Other | Group 1 - Ages 30-40, Group 2 - Ages 40-50, Group 3 - Ages 50-60 |
Primary outcome
Spearman Correlation Between BT-Analyze Mean Score and Modified Glogau Visual Aging Score
Time frame: At single study visit (Day 1)
Spearman rank correlation coefficient (rs) between mean BT-Analyze hydration score (mean of seven facial zones, 0-65 units) and total modified Glogau visual aging score (0-18 points) assessed by a blinded expert cosmetologist.
1 secondary outcome
BT-Analyze Score Comparison Across Age Groups
Time frame: At single study visit (Day 1)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 Jun 2026.
- Individual participant dataSharing planned: No
Related trials for Skin Aging
RecruitingObservational study
Improved Facial Skin Quality and Quality of Life After VYC-12L Treatment in Breast Cancer Survivors
Quality of Life, Breast Neoplasms
Active, not recruiting
Integrated Actionable Aging Assessment for Cancer Patients Pilot
Breast Cancer, Hodgkin Lymphoma
Not yet recruitingObservational study
Clinical Research on Deep-Plane Rejuran S Injection for Improvement in the Apperance of Periorbital Hollowing Using a Cannula Technique
Periorbital Hollowing, Skin Aging
Not yet recruitingObservational study
Clinical Evaluation of Dual-Plane Technique PN-Based Treatment for Horizontal Neck Lines Using DNA Fragment Opmizing Technology Polynucleotide (DOT PN)
Skin Aging, Horizontal Neck Lines
Recruiting
Ultraformer MPT Combined With Fractional CO2 Versus Fractional CO2 Alone for Facial Rejuvenation
Skin Aging
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Skin Aging and Skin Hydration, run by IAS Skin Care at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 1 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Spearman Correlation Between BT-Analyze Mean Score and Modified Glogau Visual Aging Score (time frame: At single study visit (Day 1)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Jun 2026.